Used as a key intermediate in the synthesis of fluorinated quinoline-based pharmaceuticals, particularly in the development of kinase inhibitors for cancer therapy. Its structure supports binding to ATP pockets in target enzymes, enhancing selectivity and metabolic stability. Also employed in research for designing antimicrobial agents due to its ability to penetrate bacterial cell membranes. The difluoro substitution improves lipophilicity and bioavailability in drug candidates.